Advertisement
Advertisement

SGMT

SGMT logo

Sagimet Biosciences Inc. Series A Common Stock

9.06
USD
Sponsored
+0.32
+3.66%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

9.02

-0.04
-0.50%

Sagimet Biosciences Inc. Series A Common Stock Profile

About

Sagimet Biosciences Inc. is a clinical-stage biopharmaceutical company. It involved in developing novel therapeutics targeting dysfunctional metabolic pathways. Sagimet Biosciences Inc. is based in SAN MATEO, Calif.

Info & Links

CEO

David Happel

Headquarters

155 BOVET RD., SUITE 303
SAN MATEO, CA 94402, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.sagimet.com

Auditor

KPMG LLP

Share holders

47

Employees

16

Sagimet Biosciences Inc. Series A Common Stock Statistics

Valuation Measures

Market Capitalization2

556.69M

Enterprise Value

520.07M

Enterprise Value/EBITDA(ttm)

-10.67

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

2.88

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-37.57%

Return on Invested Capital(ttm)

-37.79%

Return on Assets(ttm)

-35.52%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-48.73M

Net Income Available to Common(ttm)

-43.51M

Diluted EPS(ttm)

-1.34

Share Statistics

Beta (5Y Monthly)

3.37

52-Week Change

3.78%

S&P 500 52-Week Change

21.72%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

61.75M

Dividend Yield

0.00%

Float4

28.84M

% Held by Insiders

11.50%

% Held by Institutions

87.86%

Balance Sheet

Total Cash(mrq)

104.54M

Total Cash Per Share(mrq)

1.69

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

20.34%

Quick Ratio(mrq)

20.34%

Book Value Per Share(mrq)

3.14

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.26

Free Cash Flow(ytd)

-8.61M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement